Charles River Laboratories International Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Charles River Laboratories International şirketinin toplam hissedar öz sermayesi $3.8B ve toplam borcu $2.3B olup, bu da borç-öz sermaye oranını 60.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $8.0B ve $4.2B dir. Charles River Laboratories International 'in FAVÖK'ü $608.6M faiz karşılama oranı 4.9 dur. Şirketin $210.2M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
60.1%
Borç/özkaynak oranı
US$2.30b
Borç
| Faiz karşılama oranı | 4.9x |
| Nakit | US$210.17m |
| Eşitlik | US$3.83b |
| Toplam yükümlülükler | US$4.18b |
| Toplam varlıklar | US$8.00b |
Son finansal sağlık güncellemeleri
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03Recent updates
Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
Nov 19Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You
Oct 11Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: CRL 'nin kısa vadeli varlıkları ( $1.5B ) kısa vadeli yükümlülüklerini ( $1.0B ) aşıyor.
Uzun Vadeli Yükümlülükler: CRL 'un kısa vadeli varlıkları ( $1.5B ) uzun vadeli yükümlülüklerini ( $3.2B ) karşılamamaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: CRL 'nin net borç/öz sermaye oranı ( 54.6% ) yüksek olarak değerlendiriliyor.
Borcun Azaltılması: CRL 'nin borç/öz sermaye oranı son 5 yılda 120.6% seviyesinden 60.1% seviyesine düştü.
Borç Kapsamı: CRL 'nin borcu işletme nakit akışı ( 34.6% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: CRL 'in borcuna ilişkin faiz ödemeleri EBIT ( 4.9 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.